Pregnancy and Multiple Sclerosis

Neurologic Clinics

Volumn 30, Issue 3, 2012, Pages 877-888

  Coyle, P K ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Gender issues; Multiple sclerosis; Pregnancy; Relapse

Indexed keywords

ALEMTUZUMAB; ALPHA FETOPROTEIN; CD20 ANTIBODY; DACLIZUMAB; EARLY PREGNANCY FACTOR; ESTRADIOL; ESTRIOL; FAS LIGAND; FINGOLIMOD; FUMARIC ACID DIMETHYL ESTER; GLATIRAMER; IMMUNOGLOBULIN; INDOLEAMINE 2,3 DIOXYGENASE; METHYLPREDNISOLONE; MITOXANTRONE; NATALIZUMAB; PREGNANCY ASSOCIATED PROTEIN; PROGESTERONE; PROLACTIN; RECOMBINANT BETA INTERFERON; RELAXIN; TERIFLUNOMIDE;

ADULT; BIRTH WEIGHT; BREAST FEEDING; CASE REPORT; CD4+ CD25+ T LYMPHOCYTE; CELLULAR IMMUNITY; CESAREAN SECTION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EPIDURAL ANESTHESIA; EXPANDED DISABILITY STATUS SCALE; FEMALE; FOLLOW UP; GENETIC SUSCEPTIBILITY; GESTATIONAL AGE; HEREDITY; HORMONAL REGULATION; HUMAN; HUMORAL IMMUNITY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOLOGICAL TOLERANCE; INFERTILITY THERAPY; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; PATIENT COUNSELING; PREGNANCY; PRIORITY JOURNAL; PROGNOSIS; RADIATION EXPOSURE; REVIEW; VAGINAL DELIVERY;

ADULT; FEMALE; HUMANS; MULTIPLE SCLEROSIS; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 84864297796     PISSN: 07338619     EISSN: 15579875     Source Type: Journal    
DOI: 10.1016/j.ncl.2012.05.002     Document Type: Review

References (86)

1. Chao M.J., Ramagopalan S.V., Herrera B.M., et al. MHC transmission. Insights into gender bias in MS susceptibility. Neurology 2011, 76:242-246.
2. Gardener H., Munger K.L., Chitnis T., et al. Prenatal and perinatal factors and risk of multiple sclerosis. Epidemiology 2009, 20:611-618.
3. Hedstrom A.K., Akerstedt T., Hillert J., et al. Shift work at young age is associated with increased risk for multiple sclerosis. Ann Neurol 2011, 70(5):733-741.
4. Staples J., Ponsonby A.L., Lim L. Low maternal exposure to ultraviolet radiation in pregnancy, month of birth, and risk of multiple sclerosis in offspring: longitudinal analysis. BMJ 2010, 340:c1640.
5. Montgomery S.M., Bahmanyar S., Hillert J., et al. Maternal smoking during pregnancy and multiple sclerosis amongst offspring. Eur J Neurol 2008, 15:1395-1399.
6. Mirzaei F., Michels K.B., Munger K., et al. Gestational vitamin D and the risk of multiple sclerosis in offspring. Ann Neurol 2011, 70:30-40.
7. Moll N.M., Rietsch A.M., Thomas S., et al. Multiple sclerosis normal-appearing white matter: pathology-imaging correlations. Ann Neurol 2011, 70:764-773.
8. Jobin C., Larochelle C., Parpal H., et al. Gender issues in multiple sclerosis: an update. Womens Health (Lond Engl) 2010, 6:797-820.
9. Coyle P.K., Curkendall S., Johnson B.H., et al. Prevalence of Pregnancy in Multiple Sclerosis [abstract]. Neurology 2011, 76(Suppl 4):A611.
10. Hellwig K., Brune N., Haghikia A., et al. Reproductive counseling, treatment and course of pregnancy in 73 German MS patients. Acta Neurol Scand 2008, 118:24-28.
11. Laplaud D.A., Leray E., Barriere P., et al. Increase in multiple sclerosis relapse rate following in vitro fertilization. Neurology 2006, 66:1280-1281.
12. Hellwig K., Beste C., Brune N., et al. Increased MS relapse rate during assisted reproduction technique. J Neurol 2008, 255:592-593.
13. Hellwig K., Schimrigk S., Beste C., et al. Increase in relapse rate during assisted reproduction technique in patients with multiple sclerosis. Eur Neurol 2009, 61:65-68.
14. Lee M., O'Brien P. Multiple sclerosis and pregnancy. J Neurol Neurosurg Psychiatry 2006, 79:1308-1311.
15. Vukusic S., Confavreux C. Pregnancy and multiple sclerosis: the children of PRIMS. Clin Neurol Neurosurg 2006, 108:266-270.
16. Runmarker B., Andersen O. Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis. Brain 1995, 118:253-261.
17. D'hooghe M.B., Nagels G., Uitdehaag B.M. Long-term effects of childbirth in MS. J Neurol Neurosurg Psychiatry 2010, 81:38-41.
18. Verdru P., Theys P., D'hooghe M.B., et al. Pregnancy and multiple sclerosis: the influence on long-term disability. Clin Neurol Neurosurg 1994, 96:38-41.
19. D'hooghe M.B., Haentjens P., Nagels G., et al. Menarche, oral contraceptives, pregnancy and progression of disability in relapsing onset and progressive onset multiple sclerosis. J Neurol 2012, 259(5):855-861.
20. Koch M., Uyttenboogaart M., Heersema D., et al. Parity and secondary progression in multiple sclerosis. J Neurol Neurosurg Psychiatry 2009, 80:676-678.
21. Finkelsztejn A., Brooks J.B.B., Paschoal F.M., et al. What can we really tell women with multiple sclerosis regarding their pregnancy? A systematic review and meta-analysis of the literature. BJOG 2011, 118:790-797.
22. Tsui A., Lee M.A. Multiple sclerosis and pregnancy. Curr Opin Obstet Gynecol 2011, 23:435-439.
23. Chen Y.H., Lin H.L., Lin H.C. Does multiple sclerosis increase risk of adverse pregnancy outcomes? A population-based study. Mult Scler 2009, 15:606-612.
24. Dahl J., Myhr K.M., Daltveit A.K., et al. Pregnancy, delivery and birth outcome in different stages of maternal multiple sclerosis. J Neurol 2008, 255:623-627.
25. Jalkanen A., Alanen A., Airas L., et al. Pregnancy outcome in women with multiple sclerosis: results from a prospective nationwide study in Finland. Mult Scler 2010, 16:950-955.
26. van der Kop M.L., Pearce M.S., Dahlgren L., et al. Neonatal and delivery outcomes in women with multiple sclerosis. Ann Neurol 2011, 70:41-50.
27. Airas L., Nikula T., Huang Y.H., et al. Postpartum activation of multiple sclerosis is associated with down-regulation of tolerogenic HLA-G. J Neuroimmunol 2007, 187:205-211.
28. Bloch E.M., Reed W.F., Lee T.H., et al. Male microchimerism in peripheral blood leukocytes from women with multiple sclerosis. Chimerism 2011, 2:6-10.
29. Borchers A.T., Naguwa S.M., Keen C.L., et al. The implications of autoimmunity and pregnancy. J Autoimmun 2010, 34:287-299.
30. Kumpel B.M., Manoussaka M.S. Placental immunology and maternal alloimmune responses. Vox Sang 2012, 102:2-12.
31. Langer-Gould A., Gupta R., Huang S., et al. Interferon-γ-producing T cells, pregnancy, and postpartum relapse of multiple sclerosis. Arch Neurol 2010, 67:51-57.
32. Lashley L., van der Hoorn M.L., van der Mast B.J., et al. Changes in cytokine production and composition of peripheral blood leukocytes during pregnancy are not associated with a difference in the proliferative immune response to the fetus. Hum Immunol 2011, 72:805-811.
33. Neuteboom R.F., Verbraak E., Wierenga-Wolf A.F., et al. Pregnancy-induced fluctuations in functional T-cell subsets in multiple sclerosis patients. Mult Scler 2010, 16:1073-1078.
34. Nicot A.B. Gender and sex hormones in multiple sclerosis pathology and therapy. Front Biosci 2009, 14:4477-4515.
35. Nikbin B., Bonab M.M., Talebian F. Microchimerism and stem cell transplantation in multiple sclerosis. Int Rev Neurobiol 2007, 79:173-202.
36. Nussinovitch U., Shoenfeld Y. The role of gender and organ specific autoimmunity. Autoimmun Rev 2012, 11(6-7):A377-A385.
37. Saraste M., Vaisanen S., Alanen A., et al. Clinical and immunologic evaluation of women with multiple sclerosis during and after pregnancy. Gend Med 2007, 4:45-55.
38. Willer C.J., Herrera B.M., Morrison K.M., et al. Association between microchimerism and multiple sclerosis in Canadian twins. J Neuroimmunol 2006, 179:145-151.
39. Confavreux C., Hutchinson M., Hours M.M., et al. Rate of pregnancy-related relapse in multiple sclerosis. N Engl J Med 1998, 339:285-291.
40. Van Walderven M.A., Tas M.W., Barkhof F., et al. Magnetic resonance evaluation of disease activity during pregnancy in multiple sclerosis. Neurology 1994, 44:327-329.
41. Holmqvist P., Hammar M., Landtblom A.M., et al. Age at onset of multiple sclerosis is correlated to use of combined oral contraceptives and childbirth before diagnosis. Fertil Steril 2010, 94:2835-2837.
42. Nielsen N.M., Jorgensen K.T., Stenager E., et al. Reproductive history and risk of multiple sclerosis. Epidemiology 2011, 22:546-552.
43. Vukusic S., Hutchinson M., Hours M., et al. Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of postpartum relapse. Brain 2004, 127:1353-1360.
44. Vukusic S., Ionescu I., El-Etr M., et al. The prevention of postpartum relapses with Progestin and Estradiol in multiple sclerosis (POPART'MUS) trial: rationale, objectives and state of advancement. J Neurol Sci 2009, 286:114-118.
45. Paavilainen T., Kurki T., Färkkilä M., et al. Lower brain diffusivity in postpartum period compared to late pregnancy: results from a prospective imaging study of multiple sclerosis patients. Neuroradiology 2011, [Epub ahead of print].
46. Paavilainen T., Kurki T., Parkkola R., et al. Magnetic resonance imaging of the brain used to detect early postpartum activation of multiple sclerosis. Eur J Neurol 2007, 14:1216-1221.
47. Lebrun C., Le Page E., Kantarci O., et al. Impact of pregnancy on conversion to clinically isolated syndrome in a radiologically isolated syndrome cohort. Mult Scler 2012, [Epub ahead of print].
48. Ponsonby A.L., Lucas R.M., van der Mei I.A., et al. Offspring number, pregnancy, and risk of a first clinical demyelinating event: the autoimmune study. Neurology 2012, 78:967-974.
49. Daumer M., Weinshenker B.G., Voskuhl R. Pregnancy: a "modifiable" risk factor in MS?. Neurology 2012, 78:846-848.
50. Ramagopalan S.V., Valdar W., Dyment D.A., et al. No effect of preterm birth on the risk of multiple sclerosis: a population based study. BMC Neurol 2008, 8:30.
51. Ramagopalan S.V., Herrera B.M., Valdar W., et al. No effect of birth weight on the risk of multiple sclerosis. A population-based study. Neuroepidemiology 2008, 31:181-184.
52. Bamford C., Sibley W., Laguna J. Anesthesia in multiple sclerosis. Can J Neurol Sci 1978, 5:41-44.
53. Levesque P., Marsepoil T., Venutolo P.H., et al. Multiple sclerosis revealed by spinal anesthesia. Ann Fr Anesth Reanim 1988, 7:68-70.
54. Stenuit J., Marchand P. Les sequelles de Rachi-Anaesthesie. Acta Neurol Belg 1968, 86:626-635.
55. Perlas A., Chan V.W. Neuraxial anesthesia and multiple sclerosis. Can J Anaesth 2005, 52:454-458.
56. Achiron A., Kishner I., Dolev M., et al. Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosis. J Neurol 2004, 251:1133-1137.
57. Achiron A., Rotstein Z., Noy S., et al. Intravenous immunoglobulin treatment in the prevention of childbirth-associated acute exacerbations in multiple sclerosis. J Neurol 1996, 243:25-28.
58. Haas J., Hommes O.R. A dose comparison study of IVIG in postpartum relapsing-remitting multiple sclerosis. Mult Scler 2007, 13:900-908.
59. Confavreux C. Intravenous immunoglobulins, pregnancy and multiple sclerosis. J Neurol 2004, 251:1138-1139.
60. Durelli L., Isoardo G. High-dose intravenous immunoglobulin treatment of multiple sclerosis. Neurol Sci 2002, 23:S39-S48.
61. Haas J. High dose IVIG in the postpartum period for prevention of exacerbations in MS. Mult Scler 2000, 6:S18-S20.
62. De Seze J., Chapelotte M., Delalande S., et al. Intravenous corticosteroids in the postpartum period for reduction of acute exacerbations in multiple sclerosis. Mult Scler 2004, 10:596-597.
63. Herrera B.M., Ramagopalan S.V., Orton S., et al. Parental transmission of MS in a population-based Canadian cohort. Neurology 2007, 69:1208-1212.
64. Hoppenbrouwers I.A., Liu F., Aulchenko Y.S., et al. Maternal transmission of multiple sclerosis in a Dutch population. Arch Neurol 2008, 65:345-348.
65. Hellwig K., Haghikia A., Gold R. Parenthood and immunomodulation in patients with multiple sclerosis. J Neurol 2010, 257:580-583.
66. Fernandez Liguori N., Klajn D., Acion L., et al. Epidemiological characteristics of pregnancy, delivery, and birth outcome in women with multiple sclerosis in Argentina (EMEMAR study). Mult Scler 2009, 15:555-562.
67. Boskovic R., Wide R., Wolpin J., et al. The reproductive effects of beta interferon therapy in pregnancy. Neurology 2005, 65:807-811.
68. Hellwig K., Agne H., Gold R. Interferon beta, birth weight and pregnancy in multiple sclerosis. J Neurol 2009, 256:830-831.
69. Patti F., Cavallaro T., Lo Fermo S., et al. Is in utero early-exposure to interferon beta a risk factor for pregnancy outcomes in multiple sclerosis?. J Neurol 2008, 255:1250-1253.
70. Sandberg-Wollheim M., Frank D., Goodwin T.M., et al. Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis. Neurology 2005, 65:802-806.
71. Sandberg-Wollheim M., Alteri E., Stam Moraga M., et al. Pregnancy outcomes in multiple sclerosis following subcutaneous interferon beta-1a therapy. Mult Scler 2011, 17:423-430.
72. Coyle P.K., Johnson K., Stark Y., et al. Pregnancy outcomes in patients with multiple sclerosis treated with glatiramer acetate (Copaxone). J Neurol Neurosurg Psychiatry 2003, 74:443.
73. Fragoso Y.D., Finkelsztejn A., Kaimen-Maciel D.R., et al. Long-term use of glatiramer acetate by 11 pregnant women with multiple sclerosis: a retrospective, multicentre case series. CNS Drugs 2010, 24:969-976.
74. Salminen H.J., Leggett H., Boggild M., et al. Glatiramer acetate exposure in pregnancy: preliminary safety and birth outcomes. J Neurol 2010, 257:2020-2023.
75. Amato M.P., Portaccio E., Ghezzi A., et al. Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis. Neurology 2010, 75:1794-1802.
76. De las Heras V., De Andres C., Tellez N., et al. Pregnancy in multiple sclerosis patients treated with immunomodulators prior to or during part of the pregnancy: a descriptive study in the Spanish population. Mult Scler 2007, 13:981-984.
77. Finkelsztejn A., Fragoso Y.D., Ferreira M.L., et al. The Brazilian database on pregnancy in multiple sclerosis. Clin Neurol Neurosurg 2011, 113:277-280.
78. Lu E., Dahlgren L., Sadovnick A.D., et al. Perinatal outcomes in women with multiple sclerosis exposed to disease-modifying drugs. Mult Scler 2012, 18(4):460-467.
79. Weber-Schoendorfer C., Schaefer C. Multiple sclerosis, immunomodulators, and pregnancy outcome: a prospective observational study. Mult Scler 2009, 15:1037-1042.
80. Bayas A., Penzien J., Hellwig K. Accidental natalizumab administration to the third trimester of pregnancy in an adolescent patient with multiple sclerosis. Acta Neurol Scand 2011, 124:290-292.
81. Hellwig K., Haghikia A., Gold R. Pregnancy and natalizumab: results of an observational study in 35 accidental pregnancies during natalizumab treatment. Mult Scler 2011, 17:958-963.
82. Hoevenaren I.A., de Vries L.C., Rijnders R.J.P., et al. Delivery of healthy babies after natalizumab use for multiple sclerosis: a report of two cases. Acta Neurol Scand 2011, 123:430-433.
83. Langer-Gould A., Huang S.M., Gupta R., et al. Exclusive breastfeeding and the risk of postpartum relapses in women with multiple sclerosis. Arch Neurol 2009, 66:958-963.
84. Langer-Gould A., Huang S.M., Van Den Eeden S.K., et al. Vitamin D, pregnancy, breastfeeding, and postpartum multiple sclerosis relapses. Arch Neurol 2011, 68:310-313.
85. Portaccio E., Ghezzi A., Hakiki B., et al. Breastfeeding is not related to postpartum relapses in multiple sclerosis. Neurology 2011, 77:145-150.
86. Gilli F., Lindberg R.L., Valentino P., et al. Learning from nature: pregnancy changes the expression of inflammation-related genes in patients with multiple sclerosis. PLoS One 2010, 5:e8962.